Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Single-inhaler triple therapy fluticasone furoate
Final published version, 800 KB, PDF document
Original language | English |
---|---|
Journal | Respiratory research |
Volume | 21 |
Number of pages | 12 |
ISSN | 1465-9921 |
DOIs | |
Publication status | Published - 2020 |
- COPD, Triple therapy, LAMA/LABA, ICS/LABA, Cardiovascular safety
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 243905687